Premium
2.6. Systemic lupus erythematosus, Sjögren's and antiphospholipid syndrome ‐ therapies
Author(s) -
Mok, MY,
Wu, H,
Lau, CS,
Chan, A
Publication year - 2010
Publication title -
international journal of rheumatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 41
eISSN - 1756-185X
pISSN - 1756-1841
DOI - 10.1111/j.1756-185x.2010.01501.x
Subject(s) - medicine , antiphospholipid syndrome , league , citation , rheumatology , dermatology , family medicine , library science , physics , astronomy , thrombosis , computer science
Clinical Research: 2.6 Systemic lupus erythematosus, Sjögren’s and antiphospholipid syndrome – therapiesBACKGROUND: Dendritic cells (DC), professional antigen presenting cells, are believed to play a crucial role in the pathogenesis of systemic lupus erythematosus (SLE). 1a, 25-Dihydroxyvitamin D3 (VitD3), in addition to its effect on bone metabolism, has been increasing recognized to have immunomodulatory effects …link_to_OA_fulltextThe 14th Congress of Asia Pacific League of Associations for Rheumatology, Hong Kong, China, 11-15 July 2010. In International Journal of Rheumatic Diseases, 2010, v. 13 suppl. 1, p. 114, abstract no. 068